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Abstract
To translate science into clinical practice we must first assess the quality of care that is being
delivered. The resulting information about qualitative and quantitative parameters can then be
assessed. Ultimately insights can be obtained into improving the quality of care in diabetes mellitus.
The Diabetes Quality Improvement Programme in USA has shown such an exercise is feasible. A
similar exercise in India is necessary to improve the quality of diabetes care.
Background
Complications in diabetes can be reduced by good glyc-
emic control [1,2], and by correction of coexisting abnor-
malities such as dyslipidemia and hypertension [3]. In
addition, lifestyle factors such as lack of physical exercise
and smoking are potentially correctable. They are com-
mon in persons with diabetes who present for medical
attention [4]. The bottleneck in diabetes care is not lack of
evidence, but difficulty in implementing what is already
known [5].
It is necessary to assess the quality of care that is being
delivered so that it serves as a benchmark for further
improvement.
Domains of quality
Quality can be assessed on the following areas (a) Well
being, quality of life [6], (b) Clinical and biochemical
parameters (c) Economic aspects [7].
All three components are important in chronic lifestyle
diseases such as diabetes mellitus, where we aim at care
rather than cure [6]. One must carefully consider a combi-
nation of all three aspects and must not aim for improve-
ment in one area, to the exclusion of others.
Assessment of quality
Guidelines must be available to assess the quality of care
in diabetes. The Diabetes Quality Improvement Pro-
gramme (DQIP) [8] identified 'standardized' uniform
performance measures for diabetes care, following a
national consensus on care assessment.
At the outset a distinction must be made between per-
formance measures and care guidelines. Performance
measures assess level of care delivered across an entire pop-
ulation, whereas care guidelines recommend desired level
of care for a single patient.
The aim and requirements of the DQIP were to develop a
measurement set that is both accepted and implementa-
ble. Necessarily that required organizational, financial
and logistical support.
The operating group was broad based and included nearly
all of the organizations concerned with delivery of diabe-
tes care, including but not limited to American Diabetes
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Similarly the technical expert panel comprised a broad
section of professionals: endocrinologists, internists, fam-
ily physicians, dieticians, educators, nurses, epidemiolo-
gists, and experts in performance measurement. The last
was critical in providing expertise in an area where clini-
cians are not generally competent. When such a study is
carried out in India, the experience derived from the DQIP
can serve as a framework.
The accountability measures had to be comprehensive yet
parsimonious to minimize the burden of data collection.
If they were so elaborate to collect information, the very
purpose is lost. Similarly the data must be sufficient to
draw valid conclusions. Extensive pre release evaluation
was carried out in the development stages. Similarly data
collection feasibility studies were also done, using paper
forms and electronic format. Meticulous planning and
execution led to the success of the programme.
Ultimately what contributed to its success were: (a) belief
that opportunities exist to reduce burden of diabetes, (b)
assessment of quality of care improves diabetes care (c)
centralized performance measures gives 'collective power'.
The motto was to ultimately translate science into clinical
practice.
Following the DQIP, sub studies were done, such as
SCRIPT: Study of Clinically Relevant Indicators of Phar-
macologic Therapy. Ultimately DQIP could form a tem-
plate for performance assessment. An assessment was
made of the percentage of patients with diabetes between
18 and 75 who had each of the following investigations or
results during a one year period: HbA1c tested at least
once, poor HbA1c level (ie high), ocular fundus exam-
ined, lipid profile done, lipid control (LDL<130 mg/dl),
monitor for nephropathy, blood pressure control, foot
exam done.
Doctors had flow sheets and reference sheets. Patients and
families had access to brochures, health records and
reminder cards.
MedQuest software contains software for data entry sys-
tem design and for data collection. MedQuest software
components included those for Data entry to capture data,
Analyzer to build variables, clinical indicators, manager
for system environment, quality performance in patients,
lexicon database and an ICD9 database.
Application to clinical care
Outcomes can be predicted on the basis of biographical
and clinical variables. For examples a recent study has
shown that the following characteristics were predictive of
standard care: those aged 18–24 years, more clinic visits,
use of insulin, and area with more beds [9]. The measures
are applicable and practical. However it is necessary that
the information must be utilized to improve quality of
care [10]. Mere documentation is a job only half done.
Similarly psychological variables predicted better quality
of life. Subjects with strong belief in self-efficacy and an
optimistic outlook had better satisfaction and quality of
life [11].
Patient education must be comprehensive and include:
information about diabetes and its treatment, nutritional
management, physical activity, medications, glycemic
monitoring, prevention, detection and treatment of com-
plications, and finally psychosocial adjustment [12].
Evaluating compliance might uncover indicators such as
cultural background and ethnicity [13]. Or physical barri-
ers can be identified such as transportation, cost and com-
mitment [14]. It is also possible that some of the
observations may suggest cost-effective delivery of health
care by primary care physicians rather than sub-specialist
endocrinologists or diabetologists: a multi centric study of
processes and outcomes among groups of specialist phy-
sicians and generalists showed that there was no signifi-
cant difference in outcomes with specialist physicians,
other than better patient satisfaction [15].
Applicability to developing countries
Assessing quality of care is comparable to applied
research. Evidence is available that metabolic and glyc-
emic control prevent and postpone complications. We
must put the evidence to practice. In view of Indian diabe-
tes centres with large computerized databases, baseline
data analysis is possible. This provides information of age
structure, sex, socio economic status, follow up, compli-
ance, as well as prevalence of cost-effective modifiable fac-
tors.
As the next step a consensus can be reached on quality
measures, which can be followed by networking different
centres, either as paper or electronic records [16,17].
While electronic networking is not yet widely available
the advantages of electronic records are obvious [18].
Connectivity can be applied to local area networking
among different work areas in one Centre, as in the
MVDSC Chennai model [17] or may be extended over a
wider geographical area, though limited to fewer clinical
care areas.Page 2 of 3
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clinical database networking offers many other advan-
tages such as improved pattern recognition, interaction
with patients, tailored health information to patients, and
secondary evidence based database development [18].
Published literature has shown that in busy primary care
practices electronic medical records and computerized
tracking systems are necessary to sustain improved diabe-
tes care [19]. A companion presentation on electronic
management system (EMS) concluded that EMS
improved performance outcomes, but not metabolic out-
comes [20]. Therefore longer study involving new care
delivery models may be needed to improve metabolic
outcomes (ie better glycemic control, lower blood pres-
sure, correction of dyslipidemia), along with performance
outcomes (ie, carrying out the tests).
A variety of data mining methods can be employed to
extract information data that would be generated [21-23].
These may provide novel associations that are useful to
both clinicians and administrators. The goal is to make
available medical knowledge more functional.
A beginning has been made in an international study, the
Diabetes Care Excellence Project (DCEP) involving seven
clinics, including MV Diabetes Specialities Center in India
[21]. The purpose of the study is to 'document standard
definition used at different centers on an international
basis, and to assess the feasibility of collection and com-
parison of data on quality of care in diabetes in real-life
settings.'
Conclusion
Given the availability of robust evidence-based data for
achieving metabolic control, it is necessary to translate
principles to practice. Putting in place quality improve-
ment systems is a crucial part of this translation.
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